Research of genetic polymorphism for the risk of radiation pneumonitis after stereotactic body radiotherapy in lung cancer patients

Research of genetic polymorphism for the risk of radiation pneumonitis after stereotactic body radiotherapy in lung cancer patients - Genetic polymorphism for the risk of radiation pneumonitis after stereotactic body radiotherapy

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000011576

Enrollment

500

Registered

2013-09-01

Start date

2013-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: pathology proven lung cancer in principle but including pathology-unproven clinically diagnosed non-small cell lung cancer previously treated or treatment planned with stereotactic body radiotherapy written informed consent can be acquired

Exclusion criteria

Exclusion criteria: written informed consent can't be acquired

Design outcomes

Primary

Measure	Time frame
Discovery of the type of genetic polymorphism as the risk factors of radiation pneumonitis after stereotactic body radiotherapy for lung cancer	—

Countries

Japan

Contacts

Public ContactHiroshi Onishi

University of Yamanashi Department of Radiology

honishi@yamanashi.ac.jp055-273-1111

Outcome results